Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 576 to 600
-
PublicationsThe Scheduling Policy Framework (SPF) is a key feature of the revised arrangements for scheduling of medicines and chemicals
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 301 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 16 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 17 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 5 statement
-
Meeting reports and recommendationsThe Australian Therapeutic Goods Advisory Council met for the fifth time on 5 August 2014
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 300 statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 296 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 297 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 298 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines, Meeting 299 statement
-
PublicationsThis statement guides decision making to help address concerns with joint replacement prostheses.
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 4 statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACCS#10 and the joint ACCS-ACMS#8
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS
-
Meeting statementsTherapeutic Goods Committee, 20 June 2014, meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 15 meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 16 meeting statement
-
PublicationsTGA approach to disclosure of commercially confidential information (CCI)
-
PublicationsInstructions for applicants on how to organise and fill out a pre-submission planning form (PPF).
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 14 meeting statement
-
Meeting statementsAdvisory Committee on Non-prescription Medicines, 6 March 2014, meeting statement
-
Meeting reports and recommendationsThe Australian Therapeutic Goods Advisory Council met for the fourth time on 4 February 2014